Kathleen A. Maguire-Zeiss

Department of Neuroscience, Georgetown University Medical Center

Affiliated withGeorgetown University Medical Center

Research Area

Biography

Kathleen A. Maguire-Zeiss has not added Biography.
If you are Kathleen A. Maguire-Zeiss and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 17	2014

Other Publications

Article	Year
Somatic mosaic approaches and the aging brain. Neurobiology of aging\| PubMed ID: 12392799	2002
Convergent pathobiologic model of Parkinson's disease. Annals of the New York Academy of Sciences\| PubMed ID: 12846984	2003
Safety of viral vectors for neurological gene therapies. Current opinion in molecular therapeutics\| PubMed ID: 15537048	2004
Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease? Brain research. Molecular brain research\| PubMed ID: 15790526	2005
Neuronal precursor-restricted transduction via in utero CNS gene delivery of a novel bipartite HSV amplicon/transposase hybrid vector. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 16412694	2006
Identification of human alpha-synuclein specific single chain antibodies. Biochemical and biophysical research communications\| PubMed ID: 16973126	2006
Effects of ex vivo transduction of mesencephalic reaggregates with bcl-2 on grafted dopamine neuron survival. Brain research\| PubMed ID: 17196186	2007
Proteomic analysis of peripheral leukocytes in Alzheimer's disease patients treated with divalproex sodium. Neurobiology of aging\| PubMed ID: 17521776	2008
Synuclein activates microglia in a model of Parkinson's disease. Neurobiology of aging\| PubMed ID: 17537546	2008
Gazing into the future: Parkinson's disease gene therapeutics to modify natural history. Experimental neurology\| PubMed ID: 18035353	2008
alpha-Synuclein: a therapeutic target for Parkinson's disease? Pharmacological research : the official journal of the Italian Pharmacological Society\| PubMed ID: 18840530	2008
Immune-directed gene therapeutic development for Alzheimer's, prion, and Parkinson's diseases. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology\| PubMed ID: 18931916	2009
Mutant alpha-synuclein overexpression mediates early proinflammatory activity. Neurotoxicity research\| PubMed ID: 19526281	2009
Gene therapy in Parkinson's disease: rationale and current status. CNS drugs\| PubMed ID: 20155994	2010
Future directions for immune modulation in neurodegenerative disorders: focus on Parkinson's disease. Journal of neural transmission (Vienna, Austria : 1996)\| PubMed ID: 20549523	2010
Alpha-synuclein mediates alterations in membrane conductance: a potential role for alpha-synuclein oligomers in cell vulnerability. The European journal of neuroscience\| PubMed ID: 20550572	2010
Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease. Nature medicine\| PubMed ID: 20729864	2010
Dopamine and paraquat enhance α-synuclein-induced alterations in membrane conductance. Neurotoxicity research\| PubMed ID: 21735318	2011
α-Synuclein Alters Toll-Like Receptor Expression. Frontiers in neuroscience\| PubMed ID: 21747756	2011
Misfolded α-synuclein and Toll-like receptors: therapeutic targets for Parkinson's disease. Parkinsonism & related disorders\| PubMed ID: 22166424	2012
Matrix metalloproteinase dependent cleavage of cell adhesion molecules in the pathogenesis of CNS dysfunction with HIV and methamphetamine. Current HIV research\| PubMed ID: 22591362	2012
Microglial activation and antioxidant responses induced by the Parkinson's disease protein α-synuclein. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology\| PubMed ID: 23054368	2013
Parkinson's disease. Sub-cellular biochemistry\| PubMed ID: 23225012	2012
Development of Inducible Leucine-rich Repeat Kinase 2 (LRRK2) Cell Lines for Therapeutics Development in Parkinson's Disease. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics\| PubMed ID: 23963789	2013